Source: National Institute on Drug Abuse (NIDA)
Tuesday, March 16, 2010
New Study Sheds Light on a Neurochemical Vulnerability that Could Contribute
to Psychopathic Behaviors
advertisement
Normal individuals who scored high on a measure of impulsive/antisocial
traits display a hypersensitive brain reward system, according to a brain
imaging study by researchers at Vanderbilt University. The findings provide
the first evidence of differences in the brain’s reward system that may
underlie vulnerability to what's typically referred to as psychopathy.
The study in the current issue of the journal Nature Neuroscience was
funded by the National Institute on Drug Abuse (NIDA), a component of
the National Institutes of Health.
Psychopathy is a personality disorder characterized by a combination
of superficial charm, manipulative and antisocial behavior, sensation-seeking
and impulsivity, blunted empathy and punishment sensitivity, and shallow
emotional experiences. Psychopathy is a particularly robust predictor
of criminal behavior and recidivism.
Since psychopathic individuals are at increased risk for developing
substance use problems, the Vanderbilt team decided to investigate possible
links between the brain’s reward system (activated by abused substances
and natural reward), and a behavioral trait (impulsive/antisociality)
characteristic of psychopathy. Researchers used two different technologies
to measure the brain’s reward response.
In the first experiment, positron emission tomography (PET) was used
to image the brain’s dopamine response in subjects who received a low
oral dose of amphetamine. Dopamine is a brain chemical associated with
reward and motivation.
In the second experiment, the same subjects participated in a game,
in which they could make (or lose) money while their brains were being
scanned using functional magnetic resonance imaging (fMRI).
The results in both cases show that individuals who scored high on a
personality assessment that teases out traits like egocentricity, manipulating
others, and risk taking had a hypersensitive dopamine response system.
The picture that emerges from these high resolution PET and fMRI scans
suggests that alterations in the function of the brain’s reward system
may contribute to a latent psychopathic trait.
The researchers speculate that a heightened response to an anticipated
reward could make such individuals less fearful about the consequences
of their behavior, which, combined with a reduced sensitivity to others'
emotions and resistance to learning from mistakes, could lead to the
manipulative and aggressive style of behaviors that is common in psychopaths.
The traits analyzed in this study have been previously shown to predict
antisocial behavior and substance abuse in both incarcerated and community
samples.
"By linking traits that suggest impulsivity and the potential for
antisocial behavior to an overreactive dopamine system, this study helps
explain why aggression may be as rewarding for some people as drugs are
for others," said NIDA Director Dr. Nora Volkow. "However,
while having an antisocial trait may be a driving factor, it is clearly
not sufficient to trigger aggressive behaviors; thus, we need to continue
to investigate the other contributors to psychopathy."
While the Vanderbilt researchers believe they’ve made an important first
step showing that characterizations of psychopathic behavior are closely
related to changes in brain activity, they hope to validate their findings
with new studies on individuals who have been actually diagnosed as psychopaths.
"The amount of dopamine released was up to four times higher in
people with high levels of these traits, compared to those who scored
lower on the personality profile," says Joshua Buckholtz, doctoral
candidate in neuroscience and the lead author of the study.
"Because of these exaggerated dopamine responses, individuals with
a latent psychopathic trait may become focused on a chance to get a reward,
and less able to shift their attention until they get what they’re after.
This pattern, along with other traits, could develop into psychopathic
personality disorder."
The National Institute on Drug Abuse is a component of the National
Institutes of Health, U.S. Department of Health and Human Services. NIDA
supports most of the world’s research on the health aspects of drug abuse
and addiction. The Institute carries out a large variety of programs
to inform policy and improve practice. Fact sheets on the health effects
of drugs of abuse and information on NIDA research and other activities
can be found on the NIDA home page at www.drugabuse.gov.
To order publications in English or Spanish, call NIDA's new DrugPubs
research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD)
or fax or email requests to 240-645-0227 or drugpubs@nida.nih.gov.
Online ordering is available at http://drugpubs.drugabuse.gov.
NIDA's new media guide can be found at http://drugabuse.gov/mediaguide.
The National Institutes of Health (NIH) — The Nation's Medical
Research Agency — includes 27 Institutes and Centers and is
a component of the U.S. Department of Health and Human Services. It is
the primary federal agency for conducting and supporting basic, clinical
and translational medical research, and it investigates the causes, treatments,
and cures for both common and rare diseases. For more information about
NIH and its programs, visit www.nih.gov.